Posts

CAMCEVI is the first-ever ready-to-inject sterile formulation of leuprolide for subcutaneous injection that comes in a pre-filled syringe with no mixing required. Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., is heading distribution in the United States.

Med Ad News sits down with Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories. He has more than 20 years of experience in the pharmaceutical industry with extensive knowledge and understanding of generics.

CAR T therapies have revolutionized oncology patient care. But to ensure the often lifesaving benefits of these therapies reach the right patients, life sciences companies must navigate complex decision-making and treatment processes to maximize uptake.